Combined disease modifying treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine
Objective. To compare efficacy of different variants of combined disease modifying treat- ment in rheumatoid arthritis (RA). Material and methods. 46 pts with RA (group 1a) received methotrexate 7,5 mg/week, hydroxychloroquine 200 mg/day, diclofenac 100 mg/day. 36 pts (group 1b) were treated with th...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2009-02-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/474 |